+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-01-12Number of Pages: 82

Smoking Cessation and Nicotine De-addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Smoking cessation or nicotine de-addiction can be achieved by various modes such as nicotine replacement products, e-cigarettes, anti-depressants and nicotine receptor agonists such as Zyban (bupropion), and Chantix/Champix (varenicline). Quitting smoking is also possible with or without assistance of healthcare professionals. The smoking cessation products market has been extensively analyzed on the basis of factors such as the products popularly used, success rate, and geographical reach.

The global smoking cessation and nicotine de-addiction market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the global smoking cessation and nicotine de-addiction market with respect to the segments based on the type of products, and their geographic analysis (by country). A detailed qualitative analysis of driving and restraining factors for the market growth and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global smoking cessation and nicotine de-addiction market.  

Based on type of products, the smoking cessation and nicotine de-addiction market includes nicotine replacement therapy (NRT) products, drug therapy and e-cigarettes. The NRT products market is broadly segmented into nicotine containing gums, transdermal patches, lozenges, sublingual tablets, sprays and nasal inhalers. The prominently used brands for smoking cessation are Zyban and Chantix/Champix which comprise the drug therapy segment of the market. Geographically, the market is analyzed for four major regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW) The market segments have been extensively analyzed based on usefulness, efficacy, revenue, and geographical coverage. The market size and forecast in terms of USD million for each segment has been provided for the period from 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2014 as the base year.

A competitive landscape, mapping all the market players and their respective shares in the smoking cessation and nicotine de-addiction products market for 2012 are provided in this report. Some of the major players profiled for NRT products include Johnson & Johnson, GSK, Pfizer, Takeda Pharmaceuticals Co. Ltd., Cipla, and Revolymer PLC. GSK and Pfizer lead the market for drug therapy while the key players profiled for e-cigarettes market include VMR products, and NJOY. Each of these smoking cessation and nicotine de-addiction products market players are profiled in the report considering parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.

The global smoking cessation and nicotine de-addiction products market has been segmented as follows:

Global Smoking Cessation and Nicotine De-Addiction Products Market, by Type

  • Nicotine Replacement Therapy Products
    • Nicotine Gums
    • Nicotine Transdermal Patches
    • Nicotine Lozenges
    • Nicotine Sprays
    • Nicotine Inhalers
    • Nicotine Subling ual Tablets
  • Drug Therapy
    • Zyban (bupropion)
    • Chantix/Champix (varenicline)
  • E-cigarettes

Global Smoking Cessation and Nicotine De-Addiction Products Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Rest of Asia Pacific
  • Rest of the World (RoW)
    • Latin America (LATAM)
    • Middle East and North Africa (MENA)

 

1. Preface

2. Executive Summary
     2.1. Introduction 
     2.2. Global Smoking Cessation and Nicotine De-addiction Products Market: Market Snapshot
     2.3. Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography and Analysis

3. Industry Analysis: Smoking Cessation and Nicotine De-addiction Products Market
     3.1. Introduction and Market Definition
     3.2. Market Dynamics
            3.2.1. Drivers
                     3.2.1.1. Rising awareness about smoking health hazards and smoking cessation therapy
                     3.2.1.2. Introduction of new products
                     3.2.1.3. Reimbursement for smoking cessation therapy
            3.2.2. Restraints
                     3.2.2.1. Low awareness about smoking cessation products in developing economies
                     3.2.2.2. Legal obligations dragging growth of several smoking cessation product segments
            3.2.3. Opportunity
                     3.2.3.1. Research and development
                     3.2.3.2. Market expansion in developing economies
     3.3. Market Attractiveness Analysis of Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography
     3.4. Competitive Landscape: Heat Map Analysis

4. Smoking Cessation and Nicotine De-addiction Products Market Segmentation – by Type
     4.1. Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013–2023 (US$ Mn)
     4.2. Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Nicotine Replacement Therapies, 2013–2023 (US$ Mn)
            4.2.1. Global Nicotine Gums Market Revenue, 2013–2023, (US$ Mn) and Analysis
            4.2.2. Global Nicotine Patches Market Revenue, 2013–2023, (US$ Mn) and Analysis
            4.2.3. Global Nicotine Sprays Market Revenue, 2013–2023, (US$ Mn) and Analysis
            4.2.4. Global Nicotine Inhalers Market Revenue, 2013–2023, (US$ Mn) and Analysis
            4.2.5. Global Nicotine Lozenges Market Revenue, 2013–2023, (US$ Mn) and Analysis
            4.2.6. Global Nicotine Sub lingual Tablets Market Revenue, 2013–2023, (US$ Mn) and Analysis
     4.3. Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Drug Therapy, 2013–2023 (US$ Mn)
            4.3.1. Global Bupropione (Zyban) Market Revenue, 2013–2023, (US$ Mn) and Analysis
            4.3.2. Global Varenicline (Champix, Chantix) Market Revenue, 2013–2023, (US$ Mn)
     4.4. Global E- Cigarettes Market Revenue, 2013–2023, (US$ Mn)

5. Smoking Cessation and Nicotine De-addiction Products Market Segmentation – by Geography
     5.1. Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Geography, 2013–2023 (US$ Mn)
     5.2. North America
            5.2.1. North America Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013–2023 (US$ Mn) and Analysis
            5.2.2. North America Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Country, 2013–2023 (US$ Mn) and Analysis
     5.3. Europe
            5.3.1. Europe Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013–2023 (US$ Mn) and Analysis
            5.3.2. Europe Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Country, 2013–2023 (US$ Mn) and Analysis
     5.4. Asia Pacific
            5.4.1. Asia Pacific Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013–2023 (US$ Mn) and Analysis
            5.4.2. Asia Pacific Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Country, 2013–2023 (US$ Mn) and Analysis
     5.5. Rest of the World
            5.5.1. Rest of the World Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013–2023 (US$ Mn) and Analysis
            5.5.2. Rest of the World Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Country, 2013–2023 (US$ Mn) and Analysis

6. Company Profiles
     6.1. Cipla Ltd.
     6.2. GlaxoSmithKline plc
     6.3. Imperial Tobacco Company of India Limited.
     6.4. McNeil AB
     6.5. NJOY, Inc.
     6.6. Novartis International AG
     6.7. Pfizer, Inc.
     6.8. Revolymer PLC
     6.9. Takeda Pharmaceutical Co., Ltd.

Smoking is one of the most important lifestyle factors causing death and disability. It is the main contributor to cancer and heart diseases as well as respiratory diseases which account for almost 70% of all deaths across the globe. Control on tobacco is recognized as a worldwide problem as tobacco manufacturers focus mainly on targeting the developing regions. Nicotine addiction is the second leading cause of deaths worldwide. According to the Centers for Disease Control and Prevention (CDC), around 44 million adults got addicted to cigarette smoking in 2011, with majority being from the low-income class in the U.S. Similar conditions prevail in other countries and pose an equal threat to human lives.

The products used in smoking cessation therapy include nicotine replacement therapy (NRT) products as well as prescription drugs consisting of antidepressants and nicotine receptor agonists. The NRT market segment comprises nicotine gums, transdermal patches, lozenges, nasal and oral sprays, inhalers and sublingual tablets. NRT products, except Nicotrol nasal sprays and inhaler by Pfizer, are over-the-counter (OTC) products and are easily available in convenience stores and can be ordered online. This has provided tremendous leverage for market growth. Generic and branded generic forms of bupropion are expected to pose a challenge to the branded drugs scheduled to face patent expiry in the near future. Electronic cigarettes (e-cigarette) have changed the entire course of the market with a double digit growth rate. Although e-cigarettes have been banned in some countries, the market is expected to grow at a fast rate. It has been observed that nicotine gums and lozenges are used by addicts who wish to reduce smoking. This population of reducers is different from quitters who aim to completely quit smoking. Tobacco addicts cannot simultaneously smoke while using a patch, which can be harmful to the body. Generic forms of drugs have saturated the market with variants of Zyban. Some drug developers have even initiated clinical trials for nicotine vaccines. Although developments are taking place in the drug therapy market, the NRT market also holds immense potential because of the low cost, over-the-counter and online sales.

The global smoking cessation and nicotine de-addiction products market was dominated by North America in terms of revenue in 2014, followed by Europe. The Asia Pacific region is expected to display high growth rate during the forecast period 2015 to 2023. This market is sustained by the large number of people wanting to quit smoking. Furthermore, the smoking cessation market in emerging economies of the Middle East, Latin America and Africa will add to the growth of this market. The high cost associated with smoking cessation products relative to the cost of continued smoking may discourage the use of these products and drugs, thus adversely impacting the quitting rates. According to the WHO, Australia tops the list of regions with high cigarette prices after Norway. Research on the impact of cost on accessing cessation services will consequently affect the growth of the smoking cessation products market. Developing countries are thus currently focusing on implementing various vital public health strategies which include discouragement of smoking initiation and reducing the use of tobacco. Physicians may play a key role in promoting smoking cessation because of their close contact with the public. This practice can be efficacious and cost-effective with regards to patient smoking outcome. Also, raising taxes to increase the cost of cigarettes can reduce tobacco use, cut smoking rates, and ultimately save lives. 

Smoking prevalence has been varying across the globe with many developing countries witnessing rapid increase in the prevalence rate, which will create huge health problems for the future if left unchecked. The key players dominating the global smoking cessation products market comprises GSK, Pfizer, and NJOY.

 

smoking-cessation-nicotine-de-addiction-products

 


A complete brochure for this research is available for download.

Interact with our pool of experienced analysts for any report related queries